TDF and Entekavir - Hepatitis B Reactivation

Recruiting

• Conditions: Hepatitis B Reactivation

• Registration Number: NCT06049602
• Lead Sponsor: Viral Hepatitis Society

Brief Summary

This is a non-interventional retrospective multi-center study for the patients received Entekavir or TDF for Hepatitis B prophylaxis.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-01-15
• Status Verified: 2023-09
• Study First Submitted: 2023-09-15
• Study First Submitted QC: 2023-09-15
• Last Update Submitted: 2023-09-15
• Study First Posted: 2023-09-22
• Last Update Posted: 2023-09-22
• Primary Completion: 2023-12-31
• Study Completion: 2023-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 10000

Inclusion Criteria

• Patients used entekavir or TDF for Hepatitis B prophylaxis

Exclusion Criteria

• Patients lower then 18 years old.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reactivation Rate	12 months	Percentage of patients reactivated during the Entekavir or TDF

Trial Locations

Locations (1)

Cerrahpasa Medical Faculty; 🇹🇷 Istanbul, Turkey